AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates

CFO Angie Wirick outlined the company’s early expectations for 2026 growth and discussed product adoption trends across its cardiac surgery and pain management franchises during an appearance at the ...

NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...
Barron's

Nickel Asia Corp.

Nickel Asia Corp. engages in the operation and production of of lateritic nickel mines and ore. It operates through the following segments: Mining, Power and Services. The Mining segment engages in ...

Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board

Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds ...
Barron's

Asia Vital Components Co. Ltd.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...